82
Views
0
CrossRef citations to date
0
Altmetric
Opioids and Substance Abuse

Nociceptive Flexion Reflex Threshold is No Suitable Marker for Diagnosing Opioid-Induced Hyperalgesia

, , , , &
Pages 1067-1076 | Received 20 Jul 2023, Accepted 30 Jan 2024, Published online: 14 Mar 2024

References

  • Mercadante S, Arcuri E, Santoni A. Opioid-induced tolerance and hyperalgesia. CNS Drugs. 2019;33(10):943–955. doi:10.1007/s40263-019-00660-0
  • Yi P, Pryzbylkowski P. Opioid induced hyperalgesia. Pain Med. 2015;16 Suppl 1:S32–6:doi:10.1111/pme.12914
  • Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104(3):570–587. doi:10.1097/00000542-200603000-00025
  • Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician. 2009;12(3):679–684. doi:10.36076/ppj.2009/12/679
  • Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization; 2009.
  • European Monitoring Centre for Drugs and Drug Addiction. Balancing Access to Opioid Substitution Treatment with Preventing the Diversion of Opioid Substitution Medications in Europe: Challenges and Implications. Publications Office; 2021.
  • Koller G, Schwarzer A, Halfter K, Soyka M. Pain management in opioid maintenance treatment. Expert Opin Pharmacother. 2019;20(16):1993–2005. doi:10.1080/14656566.2019.1652270
  • Voon P, Hayashi K, Milloy M-J, et al. Pain among high-risk patients on methadone maintenance treatment. J Pain. 2015;16(9):887–894. doi:10.1016/j.jpain.2015.06.003
  • Mitchell AM, Dewey CM. Chronic pain in patients with substance abuse disorder: general guidelines and an approach to treatment. Postgrad Med. 2008;120(1):75–79. doi:10.3810/pgm.2008.04.1763
  • Skljarevski V, Ramadan NM. The nociceptive flexion reflex in humans – review article. Pain. 2002;96(1):3–8. doi:10.1016/S0304-3959(02)00018-0
  • Willer J-C. Studies on pain. Effects of morphine on a spinal nociceptive flexion reflex and related pain sensation in man. Brain Res. 1985;331(1):105–114. doi:10.1016/0006-8993(85)90719-X
  • de WJC. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain. 1977;3(1):69–80. doi:10.1016/0304-3959(77)90036-7
  • Willer JC. Exploration clinique de la nociception par des techniques de réflexologie. Neurophysiologie Clinique/Clinical Neurophysiology. 1990;20(5):335–356. doi:10.1016/S0987-7053(05)80203-5
  • Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol. 2004;11(3):153–162. doi:10.1111/j.1468-1331.2004.00791.x
  • Willer JC, Bathien N. Pharmacological modulations on the nociceptive flexion reflex in man. Pain. 1977;3(2):111–119. doi:10.1016/0304-3959(77)90074-4
  • Willer JC, Bussel B. Evidence for a direct spinal mechanism in morphine-induced inhibition of nociceptive reflexes in humans. Brain Res. 1980;187(1):212–215. doi:10.1016/0006-8993(80)90507-7
  • Fields HL, Heinricher MM. Brainstem modulation of nociceptor-driven withdrawal reflexes. Ann N Y Acad Sci. 1989;563(1):34–44. doi:10.1111/j.1749-6632.1989.tb42188.x
  • Fishman MA, Kim PS. Buprenorphine for Chronic Pain: a Systemic Review. Curr Pain Headache Rep. 2018;22(12):83. doi:10.1007/s11916-018-0732-2
  • Dematteis M, Auriacombe M, D’Agnone O, et al. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opin Pharmacother. 2017;18(18):1987–1999. doi:10.1080/14656566.2017.1409722
  • Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther. 1988;43(1):72–78. doi:10.1038/clpt.1988.13
  • Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41(14):1153–1193. doi:10.2165/00003088-200241140-00003
  • Walsh NE, Schoenfeld L, Ramamurthy S, Hoffman J. Normative model for cold pressor test. Am J Phys Med Rehabil. 1989;68(1):6–11. doi:10.1097/00002060-198902000-00003
  • Annex I. Summary of product characteristics. In: Stolerman IP, Price LH, editors. Encyclopedia of Psychopharmacology. Berlin Heidelberg: Springer; 2015:1687.
  • von DF, Hackbarth M, Schneider M, Baars JH, Rehberg B. Introduction of a continual RIII reflex threshold tracking algorithm. Brain Res. 2009;1260:24–29. doi:10.1016/j.brainres.2009.01.001
  • Dowman R. Possible startle response contamination of the spinal nociceptive withdrawal reflex. Pain. 1992;49(2):187–197. doi:10.1016/0304-3959(92)90142-X
  • Rhudy JL, France CR. Defining the nociceptive flexion reflex (NFR) threshold in human participants: a comparison of different scoring criteria. Pain. 2007;128(3):244–253. doi:10.1016/j.pain.2006.09.024
  • France CR, Rhudy JL, McGlone S. Using normalized EMG to define the nociceptive flexion reflex (NFR) threshold: further evaluation of standardized NFR scoring criteria. Pain. 2009;145(1–2):211–218. doi:10.1016/j.pain.2009.06.022
  • Oaks Z, Stage A, Middleton B, Faraone S, Johnson B. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone. Discov Med. 2018;26(144):197–206.
  • Wolff BB, Kantor TG, Jarvik ME, Laska E. Response of experimental pain to analgesic drugs. 3. Codeine, aspirin, secobarbital, and placebo. Clin Pharmacol Ther. 1969;10(2):217–228. doi:10.1002/cpt1969102217
  • Mitchell LA, MacDonald RAR, Brodie EE. Temperature and the cold pressor test. J Pain. 2004;5(4):233–237. doi:10.1016/j.jpain.2004.03.004
  • Yang DZ, Sin B, Beckhusen J, Xia D, Khaimova R, Iliev I. Opioid-induced hyperalgesia in the nonsurgical setting: a systematic review. Am J Ther. 2019;26(3):e397–e405. doi:10.1097/MJT.0000000000000734
  • Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24(6):479–496. doi:10.1097/AJP.0b013e31816b2f43
  • Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 2001;93(2):155–163. doi:10.1016/S0304-3959(01)00306-2
  • Compton P, Charuvastra V, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001;63(2):139–146. doi:10.1016/S0376-8716(00)00200-3
  • Compton P, Charuvastra V, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Sympt Manage. 2000;20(4):237–245. doi:10.1016/S0885-3924(00)00191-3
  • Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90(1):91–96. doi:10.1016/S0304-3959(00)00391-2
  • Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain. 2009;10(3):316–322. doi:10.1016/j.jpain.2008.10.003
  • Athanasos P, Ling W, Bochner F, White JM, Somogyi AA. Buprenorphine maintenance subjects are hyperalgesic and have no antinociceptive response to a very high morphine dose. Pain Med. 2019;20(1):119–128. doi:10.1093/pm/pny025
  • Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G, Willer JC. The lower limb flexion reflex in humans. Prog Neurobiol. 2005;77(6):353–395. doi:10.1016/j.pneurobio.2005.11.003
  • Lee M. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145–161. doi:10.36076/ppj.2011/14/145
  • Wilson-Poe AR, Lau BK, Vaughan CW. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. Br J Pharmacol. 2015;172(2):681–690. doi:10.1111/bph.12809
  • Wilson-Poe AR, Jeong H-J, Vaughan CW. Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance. J Physiol. 2017;595(20):6541–6555. doi:10.1113/JP274157
  • Vanderah TW, Suenaga NMH, Ossipov MH, Malan TP, Lai J, Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci. 2001;21(1):279–286. doi:10.1523/JNEUROSCI.21-01-00279.2001
  • Miller JC, Boureau F, Albe-Fessard D. Supraspinal influences on nociceptive flexion reflex and pain sensation in man. Brain Res. 1979;179(1):61–68. doi:10.1016/0006-8993(79)90489-X
  • Jones SL. Descending noradrenergic influences on pain. In: Pompeiano O, Barnes CD, editors. Progress in Brain Research. Elsevier; 1991:381–394.
  • Jure FA, Arguissain FG, Biurrun Manresa JA, Andersen OK. Conditioned pain modulation affects the withdrawal reflex pattern to nociceptive stimulation in humans. Neuroscience. 2019;408:259–271. doi:10.1016/j.neuroscience.2019.04.016
  • Amiri M, Esmaili H, Hamad AH, Alavinia M, Masani K, Kumbhare D. Nociceptive flexion reflex threshold in chronic pain patients: a needed update for the current evidence. Am J Phys Med Rehabil. 2021;100(8):750–759. doi:10.1097/PHM.0000000000001626
  • Leone C, Di Lionardo A, Di Pietro G, et al. How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex. Clin Neurophysiol. 2021;132(12):2989–2995. doi:10.1016/j.clinph.2021.08.018
  • Grönroos M, Pertovaara A. Capsaicin-induced central facilitation of a nociceptive flexion reflex in humans. Neurosci Lett. 1993;159(1–2):215–218. doi:10.1016/0304-3940(93)90837-B
  • Bromm B, Treede D-R. Withdrawal reflex, skin resistance reaction and pain ratings due to electrical stimuli in man. Pain. 1980;9(3):339–354. doi:10.1016/0304-3959(80)90048-2
  • Chan C, Dallaire M. Subjective pain sensation is linearly correlated with the flexion reflex in man. Brain Res. 1989;479(1):145–150. doi:10.1016/0006-8993(89)91344-9
  • Dowman R. Spinal and supraspinal correlates of nociception in man. Pain. 1991;45(3):269–281. doi:10.1016/0304-3959(91)90051-X
  • Dowman R. A noninvasive strategy for identifying and quantifying innocuous and nociceptive peripheral afferent activity evoked by nerve stimulation. Physiol Behav. 1993;53(6):1163–1169. doi:10.1016/0031-9384(93)90374-O
  • Schall U, Katta T, Pries E, Klöppel A, Gastpar M. Pain perception of intravenous heroin users on maintenance therapy with levomethadone. Pharmacopsychiatry. 1996;29(5):176–179. doi:10.1055/s-2007-979567
  • Athanasos P, Smith CS, White JM, Somogyi AA, Bochner F, Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain. 2006;120(3):267–275. doi:10.1016/j.pain.2005.11.005
  • Peles E, Schreiber S, Hetzroni T, Adelson M, Defrin R. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. J Pain. 2011;12(1):41–50. doi:10.1016/j.jpain.2010.04.009
  • Eyler ECH. Chronic and acute pain and pain management for patients in methadone maintenance treatment. Am J Addict. 2013;22(1):75–83. doi:10.1111/j.1521-0391.2013.00308.x
  • O’Connor PG, Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med. 2000;133(1):40–54. doi:10.7326/0003-4819-133-1-200007040-00008
  • Andersen OK, Felsby S, Nicolaisen L, Bjerring P, Jensen TS, Arendt-Nielsen L. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin -- a double-blind, placebo-controlled, human experimental study. Pain. 1996;66(1):51–62. doi:10.1016/0304-3959(96)02995-8
  • Leighton GE, Hill RG, Hughes J. Intrathecal injection of a ϰ opioid agonist produces hyperalgesia in the Guinea pig. Eur. J. Pharmacol. 1988;157(2–3):241–242. doi:10.1016/0014-2999(88)90390-1
  • Wu KM, Martin WR, Kamerling SG, Wettstein JG. Possible medullary κ hyperalgesic mechanism I. A new potential role for endogenous opioid peptides in pain perception. Life Sci. 1983;33(18):1831–1838. doi:10.1016/0024-3205(83)90691-4
  • Li X, Angst MS, Clark J. A murine model of opioid-induced hyperalgesia. Mol Brain Res. 2001;86(1–2):56–62. doi:10.1016/S0169-328X(00)00260-6
  • Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther. 1996;278(3):1121–1127.
  • Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB. Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem. 1997;272(46):28869–28874. doi:10.1074/jbc.272.46.28869
  • Fillingim RB. Individual differences in pain: understanding the mosaic that makes pain personal. Pain. 2017;158 Suppl 1:S11-S18:doi:10.1097/j.pain.0000000000000775\
  • Ang DC, Chakr R, France CR, et al. Association of nociceptive responsivity with clinical pain and the moderating effect of depression. J Pain. 2011;12(3):384–389. doi:10.1016/j.jpain.2010.09.004
  • Rhudy JL, Bartley EJ, Williams AE, et al. Are there sex differences in affective modulation of spinal nociception and pain? J Pain. 2010;11(12):1429–1441. doi:10.1016/j.jpain.2010.04.003
  • Rhudy JL, Bartley EJ. The effect of the menstrual cycle on affective modulation of pain and nociception in healthy women. Pain. 2010;149(2):365–372. doi:10.1016/j.pain.2010.02.041
  • Rhudy JL, Williams AE, McCabe KM, Matv N, Rambo P. Affective modulation of nociception at spinal and supraspinal levels. Psychophysiology. 2005;42(5):579–587. doi:10.1111/j.1469-8986.2005.00313.x
  • Wang R, Ding Y, Bai H, et al. Illicit heroin and methamphetamine use among methadone maintenance treatment patients in dehong prefecture of Yunnan province, China. PLoS One. 2015;10(7):e0133431. doi:10.1371/journal.pone.0133431
  • Tang X, Fan C, Wang C, et al. The risk assessment of relapse among newly enrolled participants in methadone maintenance treatment: a group-LASSO based Bayesian network study. Front Public Health. 2022;10:1032217. doi:10.3389/fpubh.2022.1032217
  • Dobler-Mikola A, Hättenschwiler J, Meili D, Beck T, Böni E, Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J Subst Abuse Treat. 2005;29(4):259–265. doi:10.1016/j.jsat.2005.08.002
  • Gollnisch G. Multiple predictors of illicit drug use in methadone maintenance clients. Addict Behav. 1997;22(3):353–366. doi:10.1016/S0306-4603(96)00024-X
  • Bromm B, Seide K. The influence of tilidine and prazepam on withdrawal reflex, skin resistance reaction and pain rating in man. Pain. 1982;12(3):247–258. doi:10.1016/0304-3959(82)90156-7
  • Ma C. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Sympt Manage. 1994;9(7):462–473. doi:10.1016/0885-3924(94)90203-8